Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quinapril for Endothelial Dysfunction in SLE
NCT00188188Phase 4Unknown
- Sponsor
- University Health Network
- Start
- Mar 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in systemic lupus erythematosus (SLE) comparing Quinapril First with Placebo First (2 arms). Primary endpoint: Flow-mediated brachial artery dilatation at 16 weeks. Status: unknown.
02
Drugs
quinapril
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT00188188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00188188.